Professional Documents
Culture Documents
organelle
reduction
membrane
blebbing &
changes
cell
mitochondrial
shrinkage
leakage
nuclear
fragmentation chromatin
condensation
Hacker., 2000
Two Caspase Pathways
Extrinsic Pathway
Death Ligand
Death Receptors
Caspases
Cell Death
Two Caspase Pathways
Intrinsic Pathway
BAX
BAK
BOK Mitochondria
BCL-Xs
BAD
BID
B IK
Cytochrome C
BIM
NIP3
BNIP3 Apoptosome
Complex
Caspases
Cell Death
Oncogenes
Oncogene: onco (cancer) gene
J. Michael Bishop and Harold Varmus (1989) Nobel
Prize in Medicine or Physiology: The Discovery of
the Cellular Origin of Retroviral Oncogenes
Proto-oncogenes: normal cellular genes usually
involved in cell growth and/or cell division
Oncogenes: a proto-oncogene that has been
activated by mutation or overexpression. Results
in a dominant gain of function phenotype
Growth Factors, Growth Factor Receptors, G-
proteins, Kinases, Gene Regulatory Proteins
Oncogene Activation
Molecular Biology of the Cell. Alberts, Bruce; Johnson, Alexander; Lewis, Julian;
Raff, Martin; Roberts, Keith; Walter, Peter. New York and London: Garland Science;
c2002
Retroviruses
Retrovirus
Cancerous
Retrovirus Oncogene
Retrovirus oncogene
Two main types of oncogenes:
Viral oncogene: gene from the retrovirus itself
Non-Viral oncogene (Cellular oncogene): genes derived
from the genes of the host cell that are in an inactive form
usually. Occasionally if the gene incorporates with the viral
genome will form a highly oncogenic virus.
Proto-oncogenes: are the form of cellular genes that
inactive normally but can incorporate with the viral
genome to produce a highly oncogenic virus.
Proto-Oncogene Oncogene
The proto-oncogene become oncogene by:
1. Mutation:
Example: mutation in Ras gene Continuous
activation of Ras by (constitutively in the GTP-bound
conformation) Unregulated cell proliferation
Cell transformation.
Proto-Oncogene Oncogene
2. Abnormal Activity:
Example: Removal of the Regulatory domain in the Raf gene
and replaced by gag gene Raf kinase domain
consciously active Cell transformation
Raf Proto-oncogene
Regulatory Domain Protein Kinase Domain
Raf oncogene
gag Protein Kinase Domain
Proto-Oncogene Oncogene
3. Gene translocation:
Example: c-myc gene is
translocated from
chromosome 8 to the IgH
on the chromosome 14
resulting in abnormal
c-myc expression
Cell transformation
Functions of oncogene
1. Growth Factor (example, Epithelium growth factor EGF ,
and platelet derived growth factor PDGF)
2. Growth Factor Receptor (Example; PDGFR)
3. Signal transudation (example; Ras, Raf, & MEK)
4. Transcription Factor (example; Jun, Fos, Elk-1 & myc)
Oncogenes
Oncogene causes cancer by affecting:
1. Cell Proliferation: (example; Ras, Raf, EGF)
2. Cell differentiation (example, PML/RAR that inhibits
the differentiation of promyelocyte to granulocyte which
will maintain the cell in its active proliferate state)
3. Cell Survival (example; Pl-3/AKT which will activate
BCL-2 inhibit Apoptosis & maintain cell
survival.
MYC Oncogene
Myc (c-Myc) is a regulator gene that codes for transcription
factor
A mutated version of Myc is found in many cancers, which
causes Myc to be constitutively expressed
Normal nondividing cells
Myc levels are low but responsive to growth signals from
the cellular environment
Dividing cells
Myc levels constantly maintained at an intermediate level
throughout cell cycle
Oncogenic MYC
Point mutation prevents MYC degradation allows for
accumulation of high levels of MYC
Increased transcriptional activity
Common Human
Oncogenes
The Cell - A Molecular Approach. Cooper, Geoffrey M. Sunderland (MA): Sinauer Associates, Inc.; c2000
Tumour Suppressor Genes
Tumour Suppressor genes: are genes that act to
inhibit cell proliferation and tumour development.
Mutated OR Inactivated
Molecular Biology of the Cell. Alberts, Bruce; Johnson, Alexander; Lewis, Julian; Raff, Martin;
Roberts, Keith; Walter, Peter. New York and London: Garland Science; c2002
Common Human Tumor Suppressor Genes
The Cell - A Molecular Approach. Cooper, Geoffrey M. Sunderland (MA): Sinauer Associates, Inc.;
c2000
Retinoblastoma (Rb) Tumor Suppressor
Gene
The Cell - A Molecular Approach. Cooper, Geoffrey M. Sunderland (MA): Sinauer Associates, Inc.; c2000
SV40
Function of Tumour Suppressor gene
PTEN
PIPII PIPIII
PI-3
AKT
BCL-2
2. Transcription factors
Repressor transcription factors: example; WT1 is a
repressor that appears to suppress transcription factor
( Insulin like growth factor) which will contribute in the
development of tumour.
Activator transcription factors: example; SMAD family
that are activated by TGF-, leading to inhibition of cell
proliferation.
Function of Tumour Suppressor gene
G1
G1 S
S
M G2 M G2
4. Induce apoptosis:
P53 release will increase Bax form
holes in the mitochondria release cytochrom c
activate apoptosis
In Males
Male
In Females
Breast/Ovarian Cancer
BRCA1 was first linked to chromosome 17q21 and subsequently
isolated in 1994.
BRCA1 encode large proteins of 1863 a. acids
BRCA1 may also play a role in transcription regulation, cell cycle
control, and development
BRCA2, on chromosome 13q12
BRCA2 encode large proteins of 3350 a. acids
BRCA1 or BRCA2 mutation may be running in a family include:
Early-onset breast cancer (before menopause) in several relatives over
different generations;
Ovarian cancer in addition to breast cancer among relatives;
Relatives who have breast cancer in both breasts;
Relatives who have had both breast and ovarian cancer;
BRCA1 or BRCA2 mutation have a significantly increased risk of
developing breast and ovarian cancer during their lifetime
LUNG CANCER
Adenocarcinoma Of Lung
Non-small Cell Lung Cancer
Gene map locus
17q21.1, 12p12.1, 11q22-q24, 11p15.5, 10p11.2, 7q34, 7p12.3-p12.1, 6q25.
2-q27,
3p22-p21.3
including SLC22A1L, TP53, KRAS2, BRAF, and EGFR, can be involved
in the pathogenesis of lung cancer.
Official Symbol: DLEC1
Official Full Name: deleted in lung and esophageal cancer 1
Gene type: protein coding
Summary: This gene contains 37 exons, spans approximately 59-kb, and is
located in the 3p22-p21.3 chromosomal segment that is commonly deleted
in various carcinomas. Several alternatively spliced transcripts have been
observed that contain disrupted coding regions and likely encode
nonfunctional proteins. Aberrant transcription of this gene may be involved
in carcinogenesis of the lung, esophagus, and kidney.
Official Symbol: SLC22A18
Official Full Name: solute carrier family 22 (organic cation
transporter
Gene type: protein coding
Summary: This gene is one of several tumor-suppressing sub
transferable fragments located in the imprinted gene domain of
11p15.5, an important tumor-suppressor gene region.
Alterations in this region have been associated with the Wilms
tumor, adrenocortical carcinoma, and lung, ovarian, and breast
cancer. This gene may play a role in malignancies and disease
that involve this region as well as the transport of chloroquine-
and quinidine-related compounds in the kidney.